Page last updated: 2024-11-13

bactobolin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bactobolin: from Pseudomonas sp. BN-183; has MF C14-H20-Cl2-N2-O6; RN given refers to parent cpd(R*)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54676871
CHEMBL ID489472
CHEBI ID138579
SCHEMBL ID23359158
SCHEMBL ID23370256
MeSH IDM0084430

Synonyms (27)

Synonym
NCI60_002819
y-12278
72615-20-4
mls002702960 ,
NSC325014 ,
propanamide,4,4a,5,6,7-hexahydro-5,6,8-trihydroxy-3-methyl-1-oxo-1h-2-benzopyran-4-yl]-, [3s-[3.alpha.,4.alpha.(r*),4a.beta.,5.beta.,6.alpha.]]-
nsc-325014
bactobolin
propanamide,4,4a,5,6,7-hexahydro-5,6,8-trihydroxy-3-methyl-1-oxo-1h-2-benzopyran-4-yl-, (3s-(3.alpha.,4.alpha.(r*),4a.beta.,5.beta.,6.alpha.))-
2-amino-n-[3-(dichloromethyl)-3,4,4a,5,6,7- hexahydro-5,6,8-trihydroxy-3-methyl-1-oxo-1h-2- benzopyran-4-yl], propanamide
(2s)-n-[(3s,4r,4ar,5r,6r)-3-(dichloromethyl)-5,6,8-trihydroxy-3-methyl-1-oxo-4a,5,6,7-tetrahydro-4h-isochromen-4-yl]-2-amino-propanamide
propanamide, 2-amino-n-(3-(dichloromethyl)-3,4,4a,5,6,7-hexahydro-5,6,8-trihydroxy-3-methyl-1-oxo-1h-2-benzopyran-4-yl)-, (3s-(3alpha,4alpha(r*),4abeta,5beta,6alpha))-
bn 183b
y 12278
nsc 325014
antibiotic bn 183b
(-)-bactobolin
(2s)-n-[(3s,4r,4ar,5r,6r)-3-(dichloromethyl)-1,5,6-trihydroxy-3-methyl-8-oxo-4a,5,6,7-tetrahydro-4h-isochromen-4-yl]-2-aminopropanamide
CHEMBL489472
eof7s67hs2 ,
unii-eof7s67hs2
DTXSID20222944
propanamide, 2-amino-n-((3s,4r,4ar,5r,6r)-3-(dichloromethyl)-3,4,4a,5,6,7-hexahydro-5,6,8-trihydroxy-3-methyl-1-oxo-1h-2-benzopyran-4-yl)-, (2s)-
CHEBI:138579
SCHEMBL23359158
SCHEMBL23370256
AKOS040750701

Research Excerpts

Overview

summarize : Bactobolin is a hybrid natural product with potent cytotoxic activity.

ExcerptReferenceRelevance
"Bactobolin is a hybrid natural product with potent cytotoxic activity. "( The Chemistry and Biology of Bactobolin: A 10-Year Collaboration with Natural Product Chemist Extraordinaire Jon Clardy.
Chandler, JR; Greenberg, EP; Seyedsayamdost, MR, 2020
)
2.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
amino acid amideAn amide of an amino acid formed formally by conversion of the carboxy group to a carboxamido group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID409951Inhibition of human liver MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID409949Inhibition of human liver MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (26.92)18.7374
1990's6 (23.08)18.2507
2000's3 (11.54)29.6817
2010's7 (26.92)24.3611
2020's3 (11.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.71 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]